Pricing Log in Create free account

FibroBiologics Inc. (FBLG) vs Kiora Pharmaceuticals, Inc. (KPRX)

FibroBiologics Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. FibroBiologics Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($6.6M and $6.4M). Across the 9 metrics below, Kiora Pharmaceuticals, Inc. leads on 6 and FibroBiologics Inc. on 3.

Valuation

Metric FBLG KPRX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 0.47 9.40
P/B 1.31 0.52 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.62 0.66
EV/Sales n/m (0.42) 9.02
Earnings yield (584.21%) (174.20%) (32.88%)
Free cash flow yield (247.37%) (98.19%) (23.13%)

Profitability

Metric FBLG KPRX Biotechnology median
Gross margin — 85.06% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (660.08%) (56.36%) (51.96%)
Return on assets (166.14%) (39.43%) (46.06%)
Return on invested capital (932.71%) (44,053.91%) 0.00%

Growth

Metric FBLG KPRX Biotechnology median
Revenue growth (TTM) — 983.73% 6.76%
EPS growth (last fiscal year) (23.53%) (403.45%) 29.88%
Revenue growth, 5-year CAGR — 88.72% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric FBLG KPRX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.64 8.97 4.97
Net debt to EBITDA 0.31 1.33 1.01

Dividend

Metric FBLG KPRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric FBLG KPRX Biotechnology median
Market cap 6.37m 6.63m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack